TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
NVCR

Novocure Ltd

Healthcare · Medical Devices

11.30$ -4.5% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Novocure Ltd (NVCR). It shows which part of the business is growing — and which one is holding it back.

No breakdown is available for this period. Many companies only break out revenue in their annual report.

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?